Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
WD/WD-V)
Supplied as a lyophilized powder
The rejection was efficacy-based, not safety-based adverse events were limited to mild injection-site reactions
PCAC review (July 2026) The FDA stated it intends to consult the Pharmacy Compounding Advisory Committee on July 23, 2026 regarding inclusion of BPC-157 acetate and BPC-157 (free base) on the 503A bulks list
For peptides that do not dissolve cleanly in bacteriostatic water alone typically those with hydrophobic sequences or basic amino acid-rich compositions that require protonation for solubilisation the recommended approach is to first perform initial reconstitution in a small volume of 0.1% acetic acid water (also available from Peptides Lab UK) to produce a clear stock solution, before diluting further with bacteriostatic water or the relevant physiological buffer
It is not a cancer test, it has never been validated as one, and it says nothing definite about any individual
